CN107217025A - 一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 - Google Patents
一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 Download PDFInfo
- Publication number
- CN107217025A CN107217025A CN201710431985.7A CN201710431985A CN107217025A CN 107217025 A CN107217025 A CN 107217025A CN 201710431985 A CN201710431985 A CN 201710431985A CN 107217025 A CN107217025 A CN 107217025A
- Authority
- CN
- China
- Prior art keywords
- endo
- inulinase
- bacillus subtilis
- plasmid
- pma05
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000014469 Bacillus subtilis Nutrition 0.000 title claims abstract description 38
- 244000063299 Bacillus subtilis Species 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 108090000790 Enzymes Proteins 0.000 claims abstract description 34
- 239000013612 plasmid Substances 0.000 claims abstract description 32
- 102000004190 Enzymes Human genes 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 229930027917 kanamycin Natural products 0.000 claims abstract description 9
- 229960000318 kanamycin Drugs 0.000 claims abstract description 9
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims abstract description 9
- 229930182823 kanamycin A Natural products 0.000 claims abstract description 9
- 239000003550 marker Substances 0.000 claims abstract description 5
- 238000000855 fermentation Methods 0.000 claims description 17
- 230000004151 fermentation Effects 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 229920001202 Inulin Polymers 0.000 claims description 11
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 11
- 229940029339 inulin Drugs 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 238000010276 construction Methods 0.000 claims description 7
- 238000012795 verification Methods 0.000 claims description 7
- 230000003115 biocidal effect Effects 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 238000013461 design Methods 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 239000008055 phosphate buffer solution Substances 0.000 claims description 2
- 108091008146 restriction endonucleases Proteins 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 108010042407 Endonucleases Proteins 0.000 claims 1
- 102000004533 Endonucleases Human genes 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract description 20
- 241000894006 Bacteria Species 0.000 abstract description 17
- 244000005700 microbiome Species 0.000 abstract description 6
- 235000013305 food Nutrition 0.000 abstract description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 17
- 238000001976 enzyme digestion Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- ODEHMIGXGLNAKK-OESPXIITSA-N 6-kestotriose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1 ODEHMIGXGLNAKK-OESPXIITSA-N 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 108010090785 inulinase Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000010587 phase diagram Methods 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 241000186073 Arthrobacter sp. Species 0.000 description 1
- 241000228195 Aspergillus ficuum Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193399 Bacillus smithii Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 240000008892 Helianthus tuberosus Species 0.000 description 1
- 235000003230 Helianthus tuberosus Nutrition 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 241001481665 Protophormia terraenovae Species 0.000 description 1
- 241000204709 Pseudomonas mucidolens Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 244000253911 Saccharomyces fragilis Species 0.000 description 1
- 235000018368 Saccharomyces fragilis Nutrition 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000721 bacterilogical effect Effects 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229940031154 kluyveromyces marxianus Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- -1 sucrose trisaccharide oligosaccharides Chemical class 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01007—Inulinase (3.2.1.7)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种产菊粉内切酶的枯草芽孢杆菌JG‑1,该枯草芽孢杆菌JG‑1以pMA05大肠‑枯草穿梭质粒为骨架构建质粒pMA05‑inu,然后通过化学转化法转化进Bacillsu subtilis168中,通过质粒在枯草芽孢杆菌中的卡那霉素抗性筛选标记筛选出的阳性转化子。本发明还公开了产菊粉内切酶的枯草芽孢杆菌JG‑1的制备方法和应用。枯草芽孢杆菌是公认的食品安全微生物,不会存在大肠杆菌产低聚果糖的安全隐患;可以获得更高纯度的DP3,DP4,DP5聚合度的低聚果糖;枯草芽孢杆菌在产菊粉内切酶方面比其他工程菌有更高的优势。菊粉内切酶的酶活最高酶活为20.16U/ml。
Description
技术领域
本发明涉及基因工程和发酵工程技术领域,具体涉及一种产菊粉内切酶的枯草芽孢杆菌JG-1及其制备方法和应用。
背景技术
低聚果糖(Fructooligosaccharide)又称果寡糖或蔗果三糖族低聚糖,是一类双歧杆菌增殖因子,具有低热、稳定、安全无毒等特性。它是一种非消化性低聚糖,不能被动物本身分泌的消化酶水解,到达肠道后可选择性地被双歧杆菌、乳酸杆菌利用,产生对动物生长有益的有机酸和必需的维生素等;降低肠内pH值,抑制有害菌(如大肠杆菌、梭菌及腐败菌等)的增殖,减少肠道内腐败性代谢产物的生成,从而提高动物机体免疫力,改善健康状况,达到提高营养物质利用率,增强动物生产性能的目的。它是公认的益生元代表,因而受到广泛关注。糖苷水解酶第32家族包括内切菊粉酶、外切菊粉酶、蔗糖酶及内切β-2,6-果聚糖酶等,主要催化水解含β-2,6果糖苷键、β-2,1果糖苷键或β-D果糖苷键的化合物,在理论研究方面具有一定的意义,在饲料、食品、生物燃料、洗涤、制糖和医药等领域具有潜在的应用前景。因此,以菊粉为底物,在菊粉内切酶的作用下,用微生物法生产果寡糖也备受关注。
目前,寡果糖制造用酶生产菌株使用黑曲霉,将该菌在28℃含有5~10%蔗糖的培养基中振荡培养4天,生产具有果糖转移活性的菌体,这些菌体可以直接使用,也可将酶固定化后使用55-60%蔗糖溶液中每克基质添加2-5单位的果糖转移酶,60℃反应24h,反应后的糖组成为:葡萄糖(36-35%),蔗糖(10-12%),蔗果三糖(21-28%),蔗果四糖(21-24%),蔗果五糖(3-6%)。寡果糖含量在5 5-6 0%之间,(所得产品商品名称为明治寡糖G)。另外,还可以从所得转移糖混合物中除去单糖和二糖,得到高纯度的寡果糖。
目前国际上关于菊糖酶的分子生物学研究主要集中于菊糖外切酶,对菊糖外切酶的结构以及催化机制了解较深入。而对于菊糖内切酶的研究相对较少,主要局限于酶基因的克隆和异源表达。大部分的微生物中都含有菊粉外切酶的基因,但是只有少数微生物体内含有内切酶的基因,迄今已发现某些微生物能够产菊糖内切酶,如Aspergillus ficuum,Penicillium sp.,Kluyveromy-ces marxianus,Bacillus smithii,pseudomonas sp.,Xanthomonas oryzae以及Arthrobacter sp等菌种,不同来源的菊粉内切酶,其酶学性质也不相同。
发明内容
发明目的:根据现有技术的不足,本发明所要解决的技术问题是提供了能够利用菊粉生产低聚果糖的枯草芽孢杆菌(Bacillsu subtilis)重组菌株。
本发明还要解决的技术问题是提供了上述重组菌株的制备方法。
本发明还要解决的技术问题是提供了上述重组菌株的应用。
本发明还要解决的技术问题是提供了一种菊粉内切酶的制备方法。
技术方案:为了解决上述问题,本发明的技术方案是提供了一种产菊粉内切酶的枯草芽孢杆菌JG-1,该枯草芽孢杆菌JG-1以pMA05大肠-枯草穿梭质粒为骨架构建质粒pMA05-inu,然后通过化学转化法转化进Bacillsu subtilis168中,通过质粒pMA05-inu在枯草芽孢杆菌中的卡那霉素抗性筛选标记筛选出的阳性转化子。
该表达菊粉内切酶的重组菌株Bacillsu subtilis JG-1的菌学特征如下:枯草芽胞杆菌,是芽胞杆菌属的一种,单个细胞0.7~0.8×2~3微米,着色均匀。无荚膜,周生鞭毛,能运动。革兰氏阳性菌,芽孢0.6~0.9×1.0~1.5微米,椭圆到柱状,位于菌体中央或稍偏,芽孢形成后菌体不膨大。菌落表面粗糙不透明,污白色或微黄色,在液体培养基中生长时,常形成皱醭,广泛分布在土壤及腐败的有机物中,易在枯草浸汁中繁殖,故命名为枯草芽孢杆菌。
本发明的菊粉内切酶基因inu来源于霉味假单胞菌(Pseudomonas mucidolens)它的序列在NCBI中可以查到,Gene Bank登记号为AF141320.1。序列如下(对应于序列表SEQID NO:3):
ATGCACAACACAGAAGACACAGGTCTTATCGCATACTGGTCTTTCGACGAAGAAAGTGGTAAAACAGCTGTTGACGTAATCGGAAAGATGAACGACAGCATCGACTACGTTTTCAACCACGCAAGATTCAAGGCAAGTAGCGATCCACAAAGAAGAAAGGGAATCAGCGGTAACGCATTGTTGTTCGACGGATACAGTACGTGGATCAAGAGAAGCGCAGATCAAATCGGAAAGCCAGAAAACGCTTTGACACTGGAAGCATGGGTAGCACCAAGAAGTTACGAATGGGGAGATGAACAAAGGCTTAGTGCAATCGTAAACCAACACGACAGGGAAAAGAAGGAGGGATTCATCCTGGGTATGTACAGACACGGAACTTGGTCTTTGCAACTTGGACTTGACCATGAGTGGATCGAAGTTTGGAGTGAGGATCATCCACTTCCTAAGAACGAGTGGTCTTACGTGGTAGCTACTTACGACAAGAAGACAAGCATGCTGAAGCTTGCATGCCCATCTATGTTGAAGCTTTACCTGAACGGAGTAGAGGTGGCATCAAAGCAAACAACGGCACATTCAACGATCACGCCATCAAGACAAGACCTTCTGATCGGTAAAAACAACCAGGCAGTAGTACTCGCAGGAGTATTCTCACTTAACATGTTCAACGGCCTGATCGACGAGATCAAGATTTACAACCGAGCCCTGTCATCAGACGAGATTGCTTCAAGCTTCCACAGATACCTGGTACCTTACGGAGGAAAAATACCGTCAATTCCGTATGACCACCTGAAACTCGACCGTTCACTGCTGGCTGATGATAGGCATCGACCACAATATCATGTATCACCACCTGCTCATTGGATGAACGAACCACATGCTCCAATTTATTTCAACGGCCAGTATCACCTCTTTTATCAGCACAATCCGCAGGGACCTTATTGGCACCAAATTCATTGGGGGCATTGGGTGTCTGACGATTTGGTGCATTGGCGTGATCTTCCTGTTGCTTTGTCTCCTGAAAAAAATGCCGTTGACCCTGACGGAGATTGGTCAGGATCTGCTACTTATGACGAACATGGACTGCCTGTTCTGTTTTTTACCGCTGGAGATGATTCAGCTAAACCTAATCAGCGAGTCGGTCTTGCCCGTTCAACATTTGCCCAAGATGGAGATAATGACCTGGTTCATTGGGTTAAACATCCGACGCCTGTTGTGGTGCAACAACAGGGAGTTGGAAAATTTGGCGACTTTCGTGATCCTTTTGTCTGGAAAGATGGCGATACCTGGTATATGCTCGTCGGTTCTGGAACGGATGGTGAAGGTGGTACAGCGTTAGCCTATACATCTAAAAATCTGACGGAGTGGGAGTATCGTGGTCCTTTTTATATTTCGGATCATAAAAATTATCCGTATCTGGGGAAAGTCTGGGAGCTGCCGGTCCTGCTCCCGCTCGGTAAAGATAAAAAAGGCCATGATAAACATGTCTTTCTCATTTCCCCGGTCGGGGCCGGTGCGGATGTTGAAGTTTTTTATTGGATTGGCACGTTTGATAAAGAGCAGTTTCGCTTTATTCCGGATCAGAATGAGCCGCAGCTCATTGATGTCGGCGATTCGCATTTTACGGGGCCGTCTGGCATGGTTGATCCGAATACTGGGCGTAAAATACTCTTTACAATAGCGCAGGGGGAACGGACTCCGGCGTTAGATTATTCTGCGGGCTGGGCGCATAATGGGGGCTTACCGGTGAGCCTTTCGTTACGGGAAGATGGGCGCTTGGGCGTGGAACCGATTGAAGAATTGAAATCGCTTCGCGGCAAAAAACTTGTCTCCTTTACAAAAAAATCGGCGGAAGAAGCGAATGATTTACTTACAAATGTGAAAGGGGATATGTTAGAAATTATACTTGAACTTGAACCGGGCACAGCCAAACAATTTGGCATAAAAGTCCGGCGCTCCCCTGGCGGCGAAGAGGAGACTTTATTATATTATAATACCGAAGCGTCCACATTGAATGTGAATCGGATGAAAACCACCTTGGATAATTTTGAACGGAGCAAAGGCATTCAGGGCGGCAAATTGGAGTTAAATGGCGAAAATTTAAAATTACATATTTATTTAGATCGCTCCATGATTGAAGCCTATGCGAATGGGTTAAAAAGCTTAACCACCCGCGCCTATCCGAGCCGGCCGGATTCCTTAGGCTTACAGATTTGGGGGGATGGCAGCGTCAGCGTCAAATCCATGGAAGTGTGGGAAATGAATAGCGCGTTTGGCCCGACGGTGTCGGCGTATATTCCGGAACAACATGCCGATGGCGTGCAGACAAAATAA
本发明内容还包括上述的产菊粉内切酶的枯草芽孢杆菌JG-1的制备方法,包括以下步骤:
1)菊粉内切酶编码基因的获得:选定霉味假单胞菌中的菊粉内切酶的CDS序列,设计引物,调取菊粉内切酶的酶基因inu;所述引物序列如SEQ ID NO:1和SEQ ID NO:2所示;
2)表达载体pMA05-inu的构建:以大肠-枯草穿梭质粒pMA05为质粒骨架,利用限制性内切酶NdeI和BamHI双切质粒pMA05,随后采用一步克隆的方法将目的片段和双酶切质粒连接,形成质粒pMA05-inu;
3)重组菌株的构建:将步骤2)构建验证正确的质粒pMA05-inu通过化学转化法,转化进枯草芽孢杆菌中,通过卡那霉素抗性筛选标记筛选出正确的转化子即为重组菌株;
4)发酵产酶验证:采用摇瓶培养重组菌株,测定菊粉内切酶的活力,获得高效表达重组菌株的枯草芽孢杆菌JG-1。
其中,上述卡那霉素抗生素的筛选浓度为25μg/ml。
其中,上述步骤4)的培养温度为32℃,200rpm,发酵时间为24h。
其中,上述培养在250ml摇瓶中进行培养,32℃培养24h产酶量达到最大。
本发明内容还包括上述的产菊粉内切酶的枯草芽孢杆菌JG-1在制备菊粉内切酶和低聚果糖中的应用。
一种菊粉内切酶和低聚果糖的制备方法,包括以下步骤:4℃条件下,将所述的枯草芽孢杆菌JG-1发酵培养得到发酵液,9000rpm离心菌体细胞,倒掉上清,再用PH为7.4的磷酸缓冲液洗涤菌体2-3次,最后用相同体积的缓冲悬浮细胞,采用超声破碎仪破碎细胞,4℃条件下,离心破碎液10min,获得破碎后的上清液即为菊粉内切酶。
菊粉内切酶的酶活测定:用DNS测还原糖法测菊粉内切酶的酶活,由于发生显色反应,通过测定吸光度来表征菊粉内切酶的酶活。
本发明所构建的重组菌Bacillsu subtilis JG-1的应用是基于食品安全微生物产菊粉内切酶并催化产低聚果糖(FOS)。
有益效果:本发明相对于现有技术,具有以下优点:
1:枯草芽孢杆菌是公认的食品安全微生物,不会存在大肠杆菌产低聚果糖的安全隐患;
2:可以获得DP3,DP4,DP5聚合度的低聚果糖;
3:枯草芽孢杆菌在产菊粉内切酶方面比其他工程菌有更高的优势。
4、菊粉内切酶的酶活最高酶活为20.16U/ml。
附图说明
图1重组质粒pMA05-inu的构建过程;
图2重组质粒pMA05-inu酶切验证图;图a中泳道1为分子量为7500的DNA Maker,泳道2为单酶切图;泳道3为双酶切;图b中泳道1为Maker,泳道2为单酶切验证,泳道3为双酶切验证;
图3重组菌Bacillsu subtilis JG-1的发酵产酶曲线;利用发酵产酶培养基,把重组菌Bacillsu subtilis JG-1在32℃发酵,每隔4h取样200μl,12000rpm离心1min,用200μl的0.02mM,PH为7.4的PBS缓冲悬浮细胞,并进行超声破碎后,离心后,200μl酶液和800μl2%的菊粉30min灭活,取25μl加50μlDNS,在加入550μlRO水,用酶标仪测540nm处吸光度,进而计算比酶活U/ml,1U定义为反应生成1μmol/min还原糖所需要的酶量。横坐标为时间(h),发酵时间,每隔4h取样,右侧纵坐标是比酶活(U/ml),比酶活越高,说明其200μl全细胞破碎液中产酶越高;左侧纵坐标为菌体浓度,单位是cell/ml。
图4三糖、四糖、五糖的标品液相图;图4中三个峰依次是聚合度为DP5,DP4,DP3;
图5枯草芽孢杆菌表达的菊粉内切酶催化菊芋菊粉生成果寡糖的转化液的液相图;利用高效液相色谱法检测低聚果糖的聚合度,将菊粉内切酶催化菊粉后的转化液,取24h转化液,稀释,走液相色谱柱,钙柱,横坐标代表出峰时间t(min),纵坐标代表峰高(μRIU),峰面积代表不同聚合度低聚果糖的含量;根据液相性质,聚合度高的先出峰,图中3,4,5峰分别代表聚合度为5,4,3的低聚果糖;
图6酶活标准曲线;横坐标代表果糖浓度,单位为g/L,纵坐标代表吸光度,单位为L/(g.cm)。
具体实施方式
下面结合附图对本发明作更进一步的说明。
本发明实施例所使用的试剂
菊粉 | 天根生化科技(北京)有限公司 |
一步克隆酶 | 南京爱必梦生物有限公司 |
NdeI,BamHI | TaKaRa大连宝生物有限公司 |
Maker DL15000 | TaKaRa大连宝生物有限公司 |
K2HPO4 | 上海凌峰化学试剂有限公司 |
KH2PO4 | 上海凌峰化学试剂有限公司 |
DNS | 上海润成生物有限公司 |
实施例1构建重组质粒载体pMA05-inu
通过基因挖掘技术,确定目的基因为来自于霉味假单胞菌中的菊粉内切酶,设计一步克隆引物,上游引物:aaaaggagcgatttacatatgATGCACAACACAGAAGACACAGG下游引物:gagctcgactctagaggatccTTATTTTGTCTGCACGCCATCG;将目的基因PCR调取,用限制性内切酶NdeI和BamHI双切质粒载体pMA05,回收纯化后计算浓度,确定连接体系,根据同源重组的原理,采用一步克隆的方法30℃冰上连接,将连接好的反应液用热激转化法转化进DH5α中,涂布到含有100μg/ml氨苄抗生素的固体LB平板上,37℃过夜培养12h,筛选转化子(来源于南京工业大学徐虹教授课题组惠赠的质粒pMA05是一个大肠-枯草穿梭质粒,在DH5α中显示氨苄的抗性),挑4-6个菌转接到含有100μg/ml氨苄抗生素的小黑瓶中,37℃摇床200RPM培养8h,保存菌种后剩余的细胞液离心收集细胞,用提质粒试剂盒抽提质粒,将抽提后的质粒用NdeI和BamHI双酶切(10μl=5μl质粒+1μl10*K buffer+0.5μl NdeI+0.5μl BamHI+3μlddH2O)和PCR验证,双酶切1h后,通过核酸电泳验证双酶切正确,电泳图如附图2a,PCR验证有目的条带2331bp,构建好的质粒命名为pMA05-inu。单酶切的体系为(10μl=5μl质粒+1μl10*K buffer+1μl BamHI+3μl ddH2O)
实施例2:重组载体转化枯草芽孢杆菌(Bacillsu subtilis)
由于枯草表达质粒转化方法用的都是化学转化法,枯草芽孢杆菌的转化效率高一些,首先制作枯草芽孢杆菌感受态,最后分装成200μl/管,将验证正确的质粒取5μl直接加入到200μl枯草芽孢杆菌感受态中,37℃,200rpm摇菌90min,最后涂平板,卡那霉素抗生素的浓度为20μg/ml,37℃过夜培养,挑转化子,并接种到含有卡纳抗生素的液体培养基中,37℃,200rpm摇菌12h,后续按照实施例1中步骤进行酶切验证,电泳图如附图2b:泳道1为Maker,泳道2为单酶切验证,泳道3为双酶切验证。
实施例3:JG-1发酵产酶优化
将筛选得到的阳性克隆子Bacillsu subtilis JG-1,接种到500ml产酶发酵培养基中发酵产菊粉内切酶,初始最高比酶活约为1.2U/ml。对B.subtilis JG-1产菊粉内切酶条件进行优化,将JG-1接种到500ml摇瓶中,在32℃的条件下发酵,每隔4h取样,取200μl发酵液和800μl 2%的菊粉反应30min,测菊粉内切酶酶活力,随着发酵的进行,重组菌JG-1的菌体浓度(OD600nm)达到最大值,为2.5,在4℃条件下,离心,9000rpm,离心10min,获得菌体细胞,用200μl 0.02mM的磷酸盐缓冲液PBS(PH为7.4)洗涤菌体两次,最后用相同体积(200μl)的PBS重悬菌体,采用超声破碎仪破碎细胞,4℃,离心10min,获得含有菊粉内切酶的上清液,随着发酵的进行,当发酵至24h时,优化后重组菌Bacillsu subtilis JG-1的比酶活最高为20.16U/ml。实验结果参见图3。最终确定Bacillsu subtilis JG-1的产酶发酵条件为:1%的接种量,发酵温度为32℃,200rpm,发酵时间为24h。
实施例4:菊粉内切酶的酶活的检测
将200μl菊粉内切酶的上清液和800μl2%的菊粉反应30min后的反应液,放在100℃沸水中煮沸10min灭活,12000rpm离心1min,取25μl反应上清液与50μl DNS沸水中煮沸10min,发生显色反应,再加550μl RO水(优普纯水仪)稀释,用酶标仪,测540nm下的吸光值,根据标曲计算酶活,酶活定义为1U等于1min生成1μmol还原糖所需的酶量。优化后菊粉内切酶最高比酶活为20.16U/ml。标准曲线如图6。
实施例5:菊粉内切酶催化菊粉水解产低聚果糖
取细胞破碎液上清2ml加入到8ml 100g/l的用PBS配制的菊粉溶液中,55℃,200RPM,水浴摇床中反应,每隔4h取样200μl,稀释10倍后,样品过0.22μm滤膜处理,利用Ca柱,走高效液相色谱,条件为:两根Ca柱串联,柱温为80℃,流动相为纯水,流速为0.4ml/min,检测器为示差检测器RI。取催化20h的样品处理后走液相,确定产物主要为DP3,DP4,DP5聚合度的低聚果糖。结果如图5。
以上所述仅是本发明的优选实施方式,应当指出:对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
SEQUENCE LISTING
<110> 盐城工学院
<120> 一种产菊粉内切酶的枯草芽孢杆菌NG-1及其制备方法和应用
<130> SG20170524001
<160> 3
<170> PatentIn version 3.3
<210> 1
<211> 44
<212> DNA
<213> 上游引物
<400> 1
aaaaggagcg atttacatat gatgcacaac acagaagaca cagg 44
<210> 2
<211> 43
<212> DNA
<213> 下游引物
<400> 2
gagctcgact ctagaggatc cttattttgt ctgcacgcca tcg 43
<210> 3
<211> 2331
<212> DNA
<213> 于霉味假单胞菌
<400> 3
atgcacaaca cagaagacac aggtcttatc gcatactggt ctttcgacga agaaagtggt 60
aaaacagctg ttgacgtaat cggaaagatg aacgacagca tcgactacgt tttcaaccac 120
gcaagattca aggcaagtag cgatccacaa agaagaaagg gaatcagcgg taacgcattg 180
ttgttcgacg gatacagtac gtggatcaag agaagcgcag atcaaatcgg aaagccagaa 240
aacgctttga cactggaagc atgggtagca ccaagaagtt acgaatgggg agatgaacaa 300
aggcttagtg caatcgtaaa ccaacacgac agggaaaaga aggagggatt catcctgggt 360
atgtacagac acggaacttg gtctttgcaa cttggacttg accatgagtg gatcgaagtt 420
tggagtgagg atcatccact tcctaagaac gagtggtctt acgtggtagc tacttacgac 480
aagaagacaa gcatgctgaa gcttgcatgc ccatctatgt tgaagcttta cctgaacgga 540
gtagaggtgg catcaaagca aacaacggca cattcaacga tcacgccatc aagacaagac 600
cttctgatcg gtaaaaacaa ccaggcagta gtactcgcag gagtattctc acttaacatg 660
ttcaacggcc tgatcgacga gatcaagatt tacaaccgag ccctgtcatc agacgagatt 720
gcttcaagct tccacagata cctggtacct tacggaggaa aaataccgtc aattccgtat 780
gaccacctga aactcgaccg ttcactgctg gctgatgata ggcatcgacc acaatatcat 840
gtatcaccac ctgctcattg gatgaacgaa ccacatgctc caatttattt caacggccag 900
tatcacctct tttatcagca caatccgcag ggaccttatt ggcaccaaat tcattggggg 960
cattgggtgt ctgacgattt ggtgcattgg cgtgatcttc ctgttgcttt gtctcctgaa 1020
aaaaatgccg ttgaccctga cggagattgg tcaggatctg ctacttatga cgaacatgga 1080
ctgcctgttc tgttttttac cgctggagat gattcagcta aacctaatca gcgagtcggt 1140
cttgcccgtt caacatttgc ccaagatgga gataatgacc tggttcattg ggttaaacat 1200
ccgacgcctg ttgtggtgca acaacaggga gttggaaaat ttggcgactt tcgtgatcct 1260
tttgtctgga aagatggcga tacctggtat atgctcgtcg gttctggaac ggatggtgaa 1320
ggtggtacag cgttagccta tacatctaaa aatctgacgg agtgggagta tcgtggtcct 1380
ttttatattt cggatcataa aaattatccg tatctgggga aagtctggga gctgccggtc 1440
ctgctcccgc tcggtaaaga taaaaaaggc catgataaac atgtctttct catttccccg 1500
gtcggggccg gtgcggatgt tgaagttttt tattggattg gcacgtttga taaagagcag 1560
tttcgcttta ttccggatca gaatgagccg cagctcattg atgtcggcga ttcgcatttt 1620
acggggccgt ctggcatggt tgatccgaat actgggcgta aaatactctt tacaatagcg 1680
cagggggaac ggactccggc gttagattat tctgcgggct gggcgcataa tgggggctta 1740
ccggtgagcc tttcgttacg ggaagatggg cgcttgggcg tggaaccgat tgaagaattg 1800
aaatcgcttc gcggcaaaaa acttgtctcc tttacaaaaa aatcggcgga agaagcgaat 1860
gatttactta caaatgtgaa aggggatatg ttagaaatta tacttgaact tgaaccgggc 1920
acagccaaac aatttggcat aaaagtccgg cgctcccctg gcggcgaaga ggagacttta 1980
ttatattata ataccgaagc gtccacattg aatgtgaatc ggatgaaaac caccttggat 2040
aattttgaac ggagcaaagg cattcagggc ggcaaattgg agttaaatgg cgaaaattta 2100
aaattacata tttatttaga tcgctccatg attgaagcct atgcgaatgg gttaaaaagc 2160
ttaaccaccc gcgcctatcc gagccggccg gattccttag gcttacagat ttggggggat 2220
ggcagcgtca gcgtcaaatc catggaagtg tgggaaatga atagcgcgtt tggcccgacg 2280
gtgtcggcgt atattccgga acaacatgcc gatggcgtgc agacaaaata a 2331
Claims (6)
1.一种产菊粉内切酶的枯草芽孢杆菌JG-1,其特征在于,该枯草芽孢杆菌JG-1以pMA05大肠-枯草穿梭质粒为骨架构建质粒pMA05-inu,然后通过化学转化法转化进Bacillsu subtilis168中,通过质粒pMA05-inu在枯草芽孢杆菌中的卡那霉素抗性筛选标记筛选出的阳性转化子即为产菊粉内切酶的枯草芽孢杆菌JG-1。
2.权利要求1所述的产菊粉内切酶的枯草芽孢杆菌JG-1的制备方法,其特征在于,包括以下步骤:
菊粉内切酶编码基因的获得:选定霉味假单胞菌中的菊粉内切酶的CDS序列,设计引物,调取菊粉内切酶的酶基因inu;所述引物序列如SEQ ID NO:1和SEQ ID NO:2所示;
表达载体pMA05-inu的构建:以大肠-枯草穿梭质粒pMA05为质粒骨架,利用限制性内切酶NdeI和BamHI双切质粒pMA05,随后采用一步克隆的方法将目的片段和双酶切质粒连接,形成质粒pMA05-inu;
重组菌株的构建:将步骤2)构建验证正确的质粒pMA05-inu通过化学转化法,转化进枯草芽孢杆菌中,通过卡那霉素抗性筛选标记筛选出正确的转化子即为重组菌株;
发酵产酶验证:采用摇瓶培养重组菌株,测定菊粉内切酶的活力,获得高效表达重组菌株的枯草芽孢杆菌JG-1。
3.根据权利要求2所述的产菊粉内切酶的枯草芽孢杆菌JG-1的制备方法,其特征在于,所述卡那霉素抗生素的筛选浓度为25mg/ml。
4.根据权利要求2所述的产菊粉内切酶的枯草芽孢杆菌JG-1的制备方法,其特征在于,所述步骤4)的培养温度为32℃,200 rpm,发酵时间为24 h。
5.权利要求1所述的产菊粉内切酶的枯草芽孢杆菌JG-1在制备菊粉内切酶中的应用。
6.一种菊粉内切酶的制备方法,其特征在于,包括以下步骤:4℃条件下,将权利要求1所述的枯草芽孢杆菌JG-1发酵培养得到发酵液,9000 rpm离心菌体细胞,倒掉上清,再用PH为7.4的磷酸缓冲液洗涤菌体2-3次,最后用相同体积的缓冲悬浮细胞,采用超声破碎仪破碎细胞,4℃条件下,离心破碎液10 min,获得破碎后的上清液即为菊粉内切酶。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710431985.7A CN107217025A (zh) | 2017-06-09 | 2017-06-09 | 一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710431985.7A CN107217025A (zh) | 2017-06-09 | 2017-06-09 | 一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107217025A true CN107217025A (zh) | 2017-09-29 |
Family
ID=59947995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710431985.7A Pending CN107217025A (zh) | 2017-06-09 | 2017-06-09 | 一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107217025A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108467847A (zh) * | 2018-01-18 | 2018-08-31 | 盐城工学院 | 可胞外分泌菊粉内切酶的重组枯草芽孢杆菌及其制备方法和应用 |
CN109055413A (zh) * | 2018-07-30 | 2018-12-21 | 江苏医药职业学院 | 一种穿梭质粒载体及其构建方法和应用 |
CN110066777A (zh) * | 2019-04-30 | 2019-07-30 | 江南大学 | 一种内切菊粉酶及其在生产低聚果糖中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1252438A (zh) * | 1998-10-26 | 2000-05-10 | 中国农业科学院饲料研究所 | 一种产生菊粉酶的酵母菌株及其在制作高果糖浆中的应用 |
CN1594542A (zh) * | 2003-08-19 | 2005-03-16 | 中国农业科学院饲料研究所 | 黑曲霉菊粉内切酶基因和表达该基因的重组毕赤酵母菌株 |
CN103243117A (zh) * | 2013-05-24 | 2013-08-14 | 江南大学 | 一种利用重组Bacillus subtilis克隆表达粘质沙雷氏菌脂肪酶的方法 |
CN103952326A (zh) * | 2014-05-21 | 2014-07-30 | 山东大学 | 一种共表达菊粉外切酶和内切酶的重组毕赤酵母菌株及其构建方法与应用 |
CN105505899A (zh) * | 2016-01-12 | 2016-04-20 | 南京工业大学 | 一种菊粉内切酶的制备方法及其应用 |
-
2017
- 2017-06-09 CN CN201710431985.7A patent/CN107217025A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1252438A (zh) * | 1998-10-26 | 2000-05-10 | 中国农业科学院饲料研究所 | 一种产生菊粉酶的酵母菌株及其在制作高果糖浆中的应用 |
CN1594542A (zh) * | 2003-08-19 | 2005-03-16 | 中国农业科学院饲料研究所 | 黑曲霉菊粉内切酶基因和表达该基因的重组毕赤酵母菌株 |
CN103243117A (zh) * | 2013-05-24 | 2013-08-14 | 江南大学 | 一种利用重组Bacillus subtilis克隆表达粘质沙雷氏菌脂肪酶的方法 |
CN103952326A (zh) * | 2014-05-21 | 2014-07-30 | 山东大学 | 一种共表达菊粉外切酶和内切酶的重组毕赤酵母菌株及其构建方法与应用 |
CN105505899A (zh) * | 2016-01-12 | 2016-04-20 | 南京工业大学 | 一种菊粉内切酶的制备方法及其应用 |
Non-Patent Citations (4)
Title |
---|
GENBANK: "AF141320.1", 《GENBANK》 * |
KIM ET AL.: "Inulooligosaccharide production from inulin by Saccharomyces cerevisiae strain displaying cell-surface endoinulinase", 《J. MICROBIOL. BIOTECHNOL.》 * |
RUIFAN JIANG ET AL.: "One-Step Bioprocess of Inulin to Product Inulo-Oligosaccharides Using Bacillus subtilis Secreting an Extracellular Endo-Inulinase", 《APPL BIOCHEM BIOTECHNOL》 * |
YANBING XU ET AL.: "Efficient Conversion of Inulin to Inulooligosaccharides through Endoinulinase from Aspergillus niger", 《J. AGRIC. FOOD CHEM.》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108467847A (zh) * | 2018-01-18 | 2018-08-31 | 盐城工学院 | 可胞外分泌菊粉内切酶的重组枯草芽孢杆菌及其制备方法和应用 |
CN108467847B (zh) * | 2018-01-18 | 2021-11-19 | 盐城工学院 | 可胞外分泌菊粉内切酶的重组枯草芽孢杆菌及其制备方法和应用 |
CN109055413A (zh) * | 2018-07-30 | 2018-12-21 | 江苏医药职业学院 | 一种穿梭质粒载体及其构建方法和应用 |
CN109055413B (zh) * | 2018-07-30 | 2021-07-02 | 江苏医药职业学院 | 一种穿梭质粒载体及其构建方法和应用 |
CN110066777A (zh) * | 2019-04-30 | 2019-07-30 | 江南大学 | 一种内切菊粉酶及其在生产低聚果糖中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11203742B2 (en) | Sucrose phosphorylase mutant with improved enzyme activity and construction method thereof and use thereof | |
TWI675916B (zh) | 具有阿洛酮糖-3-差向異構酶活性之蛋白質及其相關用途、核酸分子、載體、宿主細胞及方法 | |
US8735106B2 (en) | Immobilization of psicose-epimerase and a method of producing D-psicose using the same | |
CN111575220B (zh) | 合成2’-岩藻糖基乳糖的重组大肠杆菌及其构建方法与应用 | |
CN112322565B (zh) | 提高重组大肠杆菌中2’-岩藻糖基乳糖产量的方法 | |
EP4276171A1 (en) | Bacillus subtilis genetically engineered bacterium for producing tagatose and method for preparing tagatose | |
CN108102995B (zh) | 一种d-阿洛酮糖3-差向异构酶生产菌株及其固定化方法 | |
CN105087456A (zh) | 一种产特定分子量透明质酸的重组枯草芽孢杆菌构建的方法 | |
CN103397064A (zh) | 一种酶法制备瑞鲍迪甙m的方法 | |
CN109609530B (zh) | 一种海藻糖合成酶及其在海藻糖生产中的应用 | |
CN110452845B (zh) | 一种产蔗糖磷酸化酶的大肠杆菌 | |
CN107937454A (zh) | 一种固定化酶催化剂生物合成d‑塔格糖的方法 | |
CN112342232B (zh) | 一种适合二糖苷转移功能的重组右旋糖酐蔗糖酶大肠杆菌的构建方法 | |
CN107217025A (zh) | 一种产菊粉内切酶的枯草芽孢杆菌jg‑1及其制备方法和应用 | |
WO2024113998A1 (zh) | 一种酶法制备超低分子量石斛寡聚糖的方法及其应用 | |
CN114317384B (zh) | 生产2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法和应用 | |
CN111455003A (zh) | 一种微藻制备d-阿洛酮糖的方法 | |
CN113699087B (zh) | 一种转化乳糖生成乳果糖的植物乳杆菌工程菌株及其构建方法与应用 | |
CN104962508A (zh) | 基于毒蛋白MazF反向筛选的表达D-阿洛酮糖3-差向异构酶的重组枯草芽孢杆菌的构建方法 | |
CN113403332A (zh) | 一种α-琼胶酶基因及其编码酶的应用 | |
CN117106835A (zh) | 用于多酶级联催化合成gdp-l-岩藻糖的生物酶组合物及其制备方法和应用 | |
WO2023169200A1 (zh) | 重组酵母菌及其应用 | |
CN114107148B (zh) | 一种高产透明质酸的基因工程菌株及其应用 | |
CN108467847A (zh) | 可胞外分泌菊粉内切酶的重组枯草芽孢杆菌及其制备方法和应用 | |
CN116515725A (zh) | 一种产聚唾液酸的重组EcN大肠杆菌及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170929 |
|
RJ01 | Rejection of invention patent application after publication |